Following this strong showing, NeuroPace raised its fiscal year 2024 revenue guidance to $78.0-$80.0 million, up from the previous range of $76.0-$78.0 million. The company also provided gross margin ...
Shares of NeuroPace stock opened at $12.95 on Friday. The business’s fifty day simple moving average is $12.69 and its 200 day simple moving average is $9.66. The firm has a market capitalization of ...
Revenue of $92 million – $96 million, representing growth of 15.5% – 20.5% versus the midpoint of the expected 2024 revenue range of $79.4 million – $79.9 million Gross margin of 73% – 75% Total ...
MOUNTAIN VIEW, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced the ...
4 analysts have shared their evaluations of NeuroPace (NASDAQ:NPCE) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table encapsulates their recent ...
NeuroPace, Inc. has successfully completed the repurchase of 5,270,845 shares of its common stock from KCK Ltd., funded by proceeds from a recent public offering. This move facilitated KCK Ltd.'s exit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback